Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Table S1 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial
  1. Home
  2. Publications
  3. Supplementary Table S1 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

Supplementary Table S1 from Beneficial Effects of Mifepristone Treatment in Patients with Breast Cancer Selected by the Progesterone Receptor Isoform Ratio: Results from the MIPRA Trial

Authors:
  • AEAndrés Elía
    Andrés Elía
  • LSLeo Saldain
    Leo Saldain
  • SVSilvia I. Vanzulli
    Silvia I. Vanzulli
  • Luisa A. Helguero
    Luisa A. Helguero
  • CLCaroline A. Lamb
    Caroline A. Lamb
  • VFVictoria Fabris
    Victoria Fabris
  • GPGabriela Pataccini
    Gabriela Pataccini
  • PMPaula Martínez-Vazquez
    Paula Martínez-Vazquez
  • JBJavier Burruchaga
    Javier Burruchaga
  • ICInes Caillet-Bois
    Ines Caillet-Bois
  • ESEunice Spengler
    Eunice Spengler
  • GHGabriela Acosta Haab
    Gabriela Acosta Haab

Open Access
Publisher website
Google Scholar
  • 25 November 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1078-0432.30707839
Abstract
Representativeness of Study Participants
Keywords
  • BREAST CANCER
  • CLINICAL TRIAL RESULTS
  • PHASE II CLINICAL TRIALS
  • ENDOCRINOLOGY
  • HORMONE SIGNALING AND INHIBITORS
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.